You just read:

Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study

News provided by

UCB

02 Mar, 2019, 14:29 GMT